153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial
Robert J. Fox, Amit Bar‐Or, Anthony Traboulsee, Celia Oreja‐Guevara, Gavin Giovannoni, Patrick Vermersch, Sana Syed, Ye Li, Wendy Vargas, Timothy J. Turner, Erik Wallstroem
Topics & Concepts
Multiple sclerosisMedicinePlaceboRelapsing remittingInternal medicinePathologyImmunologyAlternative medicineMultiple and Secondary Primary CancersLung Cancer Treatments and Mutations